IAP inhibitors (Pharmascience)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIAP inhibitors (Pharmascience)
Drug Alias NameIAP inhibitors (Aegera Therapeutics)inhibitory apoptosis proteins inhibitors (Aegera Therapeutics)IAP inhibitors (oral, rheumatoid arthritis/cancer) (Aegera/Human Genome Sciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of apoptosis protein 3 inhibitors
TargetsInhibitor of apoptosis protein 3
Therapy Area/IndicationsArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAegera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAegera Therapeutics IncHuman Genome Sciences IncPharmascience Inc
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A